Steroid Hormones
Progesterone
Last reviewed: 2026-11-19
Evidence status & limitations
Approved uses depend on the exact product; they are not approval for every reproductive application.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
Prometrium · Female Health
Prevention of endometrial hyperplasia in specified postmenopausal women with a uterus receiving estrogen, and secondary amenorrhea.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Dizziness, somnolence and thromboembolic concerns depend on formulation and clinical context.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Testosterone cypionate
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications